Stamos Capital Partners, L.P. Merck & Co., Inc. Transaction History

Stamos Capital Partners, L.P.

$407 Million
Q4 2024

A detailed history of Stamos Capital Partners, L.P. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Stamos Capital Partners, L.P. holds 123,680 shares of MRK stock, worth $11.5 Million. This represents 3.02% of its overall portfolio holdings.

Number of Shares

123,680

Previous 94,180 31.32%

Holding current value

$11.5 Million

Previous $10.7 Million 15.04%

% of portfolio

3.02%

Previous 2.6%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$96.31 - $114.76 $2.84 Million - $3.39 Million	29,500 Added 31.32%	123,680 $12.3 Million
Q3 2024 Nov 13, 2024	BUY	$111.15 - $128.97 $2.69 Million - $3.12 Million	24,190 Added 34.56%	94,180 $10.7 Million
Q2 2024 Aug 13, 2024	SELL	$123.8 - $132.96 $266,170 - $285,864	-2,150 Reduced 2.98%	69,990 $8.66 Million
Q1 2024 May 14, 2024	SELL	$113.24 - $131.95 $1.57 Million - $1.83 Million	-13,860 Reduced 16.12%	72,140 $9.52 Million
Q4 2023 Feb 13, 2024	SELL	$100.18 - $109.02 $50,090 - $54,510	-500 Reduced 0.58%	86,000 $9.38 Million
Q3 2023 Nov 13, 2023	BUY	$102.95 - $114.33 $1.27 Million - $1.41 Million	12,290 Added 16.56%	86,500 $8.91 Million
Q2 2023 Aug 11, 2023	SELL	$108.61 - $118.38 $217,220 - $236,760	-2,000 Reduced 2.62%	74,210 $8.56 Million
Q1 2023 May 12, 2023	BUY	$102.94 - $114.86 $1.64 Million - $1.83 Million	15,910 Added 26.38%	76,210 $8.11 Million
Q4 2022 Feb 13, 2023	SELL	$87.44 - $112.11 $3.31 Million - $4.24 Million	-37,830 Reduced 38.55%	60,300 $6.69 Million
Q3 2022 Nov 10, 2022	BUY	$84.53 - $94.96 $492,809 - $553,616	5,830 Added 6.32%	98,130 $8.45 Million
Q1 2022 May 13, 2022	BUY	$73.51 - $82.4 $110,265 - $123,600	1,500 Added 1.65%	92,300 $7.57 Million
Q4 2021 Feb 14, 2022	BUY	$72.28 - $90.54 $1.88 Million - $2.36 Million	26,050 Added 40.23%	90,800 $6.96 Million
Q2 2021 Aug 13, 2021	BUY	$70.31 - $77.77 $312,879 - $346,076	4,450 Added 7.38%	64,750 $5.04 Million
Q4 2020 Feb 12, 2021	BUY	$71.77 - $79.65 $2.17 Million - $2.41 Million	30,300 Added 101.0%	60,300 $4.93 Million
Q2 2020 Aug 14, 2020	SELL	$70.42 - $80.13 $1.56 Million - $1.77 Million	-22,111 Reduced 42.43%	30,000 $2.32 Million
Q1 2020 May 15, 2020	BUY	$63.36 - $87.82 $1.21 Million - $1.68 Million	19,171 Added 58.2%	52,111 $4.01 Million
Q4 2019 Feb 14, 2020	SELL	$77.58 - $87.54 $586,504 - $661,802	-7,560 Reduced 18.67%	32,940 $3 Million
Q3 2019 Nov 14, 2019	BUY	$76.08 - $82.93 $1.27 Million - $1.38 Million	16,700 Added 70.17%	40,500 $3.41 Million
Q2 2019 Aug 14, 2019	SELL	$69.84 - $81.59 $293,328 - $342,678	-4,200 Reduced 15.0%	23,800 $2.02 Million
Q1 2019 May 10, 2019	SELL	$69.58 - $79.36 $487,060 - $555,520	-7,000 Reduced 20.0%	28,000 $2.29 Million
Q4 2018 Feb 14, 2019	BUY	$65.24 - $75.71 $2.28 Million - $2.65 Million	35,000 New	35,000 $2.67 Million

Others Institutions Holding MRK

# of Institutions

3,972

Shares Held

1.94B

Call Options Held

16M

Put Options Held

15M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $236B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stamos Capital Partners, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Stamos Capital Partners, L.P. with notifications on news.

Account

Stamos Capital Partners, L.P. Merck & Co., Inc. Transaction History